Affordable Access

Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus

Authors
Journal
Transplantation Proceedings
0041-1345
Publisher
Elsevier
Publication Date
Volume
36
Issue
5
Identifiers
DOI: 10.1016/j.transproceed.2004.04.080
Keywords
  • Renal Transplantation: Complications: Other Disorders
Disciplines
  • Medicine

Abstract

Abstract Although drugs used in renal transplant recipients such as steroids, cyclosporine, and particularly, tacrolimus have diabetogenic potential, diabetic ketoacidosis is uncommon. There are few data concerning the long-term follow-up of these patients. Diabetic ketoacidosis occurred in a renal transplant recipient following de novo development associated with tacrolimus.

There are no comments yet on this publication. Be the first to share your thoughts.